Lexicon Pharmaceuticals, Inc. (LXRX) is a publicly traded Healthcare sector company. As of July 27, 2026, LXRX trades at $2.35 with a market cap of $1.02B and a P/E ratio of -32.71. LXRX moved +3.28% today. Year to date, LXRX is +99.13%; over the trailing twelve months it is +102.66%. Its 52-week range spans $0.28 to $2.68. Analyst consensus is strong buy with an average price target of $5.03. Rallies surfaces LXRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LXRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.35 |
| Market Cap | $1.02B |
| P/E Ratio | -32.71 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.68 |
| 52-Week Low | $0.28 |
| Volume | 766.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $69.64M |
| Net Income | $-26.09M |
| Gross Margin | 99.50% |
3 analysts cover LXRX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.03.